Press Releases August 21, 2026 08:00 AM

Synergy CHC Corp. Announces Receipt of Nasdaq Letter

Synergy CHC Corp. receives Nasdaq notification for delayed SEC filing, faces compliance deadline

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
SNYR

Synergy CHC Corp. announced it received a Nasdaq notice for non-compliance due to the delayed filing of its Q2 Form 10-Q quarterly report. The company has until October 19, 2026, to submit a compliance plan to Nasdaq, and potentially until February 10, 2027, to regain compliance. There's uncertainty regarding the timing of the filing, which poses risks to continued Nasdaq listing.

Synergy CHC Corp. Announces Receipt of Nasdaq Letter
SNYR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nasdaq notified Synergy CHC Corp. for delayed filing of Q2 Form 10-Q, indicating non-compliance with Listing Rule 5250(c)(1).
  • The company has 60 days to submit a compliance plan and may receive up to 180 days to regain compliance.
  • Synergy CHC Corp. markets health and wellness products with key brands like FOCUSfactor and Flat Tummy, distributed through major US and North American retailers.

N. WINDHAM, Maine, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, today announced that it received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2026, indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Q2 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Listing Rule requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC.

The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.

In accordance with Nasdaq’s listing rules, the Company has 60 calendar days after the Notice, or until October 19, 2026, to submit a plan of compliance to Nasdaq addressing how the Company intends to regain compliance with the Listing Rule. Pursuant to the Notice, Nasdaq has the discretion to grant the Company up to 180 calendar days from the Q2 Form 10-Q’s due date, or February 10, 2027, for the Company to regain compliance with the Listing Rule.

At this time, the Company is unable to predict when, or whether, the Q2 Form 10-Q will be filed. There can be no assurance that the Company will file the Q2 Form 10-Q or otherwise regain compliance with the Listing Rule.

About Synergy CHC Corp.

Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor® and Flat Tummy®. FOCUSfactor®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada and Mexico through major retailers including Walmart, Amazon, BJ’s, and Walgreens, among others. Flat Tummy® complements Synergy’s portfolio as a lifestyle brand focused on women's wellness and weight management.

Disclosure Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology. All statements other than statements of historical facts contained in this press release are forward-looking statements. In particular, forward-looking statements include, among other things, statements relating to the Company's efforts to regain compliance with Nasdaq Listing Rule 5250(c)(1), the submission and potential acceptance of a compliance plan by Nasdaq, the possibility of any extension that may be granted by Nasdaq, and the timing of any future SEC filings. These forward-looking statements are not guarantees of future results and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond our control. Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, a material delay in the Company’s financial reporting, uncertainties about the timing of the Company’s submission of a compliance plan, Nasdaq’s acceptance of any such plan, the duration of any extension that may be granted by Nasdaq, and the risk that the Company will be unable to meet Nasdaq’s continued listing requirements. We disclaim and do not undertake any obligation to update or revise any forward-looking statement in this report, except as required by applicable law or regulation. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
[email protected]


Risks

  • Uncertainty around timing or ability to file the delayed Q2 Form 10-Q may lead to Nasdaq delisting.
  • Potential negative investor sentiment due to reporting delays impacting stock liquidity and valuation.
  • Risks related to maintaining regulatory compliance in the consumer health and wellness sector, which may affect company operations and reputation.

More from Press Releases

NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight Aug 21, 2026 T3 Defense Enters the UAV and Counter-UAV (C-UAV) Platform Market Aug 21, 2026 NFT LTD Announces Pricing of US$2.0 Million Public Offering Aug 21, 2026 Reitar Logtech Holdings Limited Announces US$3 Million Share Repurchase Program Aug 21, 2026 Space-Eyes Announces Four Distinguished Appointments to Post-Combination Board of Directors Reflecting Deep National Security, Intelligence, Defense and Global Capital Markets Expertise Aug 21, 2026